Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis

International Journal of Cancer

Volumn 79, Issue 3, 1998, Pages 245-250

  Yamamura, Hisako ^a   Yoshikawa, Hideki ^a   Tatsuta, Masaharu ^a   Akedo, Hitoshi ^a   Takahashi, Katsuhito ^a,b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CALDESMON; CALPONIN;

ARTICLE; CANCER GRADING; CANCER SURVIVAL; DIAGNOSTIC VALUE; GENE EXPRESSION; HUMAN; HUMAN CELL; MARKER GENE; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SMOOTH MUSCLE CONTRACTILITY; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CALCIUM-BINDING PROTEINS; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0031778276     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980619)79:3<245::AID-IJC6>3.0.CO;2-P     Document Type: Article

References (29)

1. APPLEGATE, D., FENG, W., GREEN, R.S. and TAUBMAN, M.B., Cloning and expression of a novel acidic calponin isoform from rat vascular smooth muscle. J. biol. Chem., 269, 10683-10690 (1994).
2. CANCE, W.G., BRENNAN, M.F., DUDAS, M.E., HUANG, C.-M. and CORDON-CARDO, C., Altered expression of the retinoblastoma gene product in human sarcomas. N. Engl. J. Med., 323, 1457-1462 (1990).
3. CARUGO, K.D., BANUELOS, S. and SARASTE, M., Crystal structure of a calponin homology domain. Nature (Struct. Biol.), 4, 175-179 (1997).
4. COPPOLA, J., BRYANT, S., TODA, T., CONWAY, D. and BARBACID, M., Mechanism of activation of the vav proto-oncogene. Cell Growth Differ., 2, 95-105 (1991).
5. DAVIS, A.M., BELL, R.S. and GOODWIN, P.J., Prognostic factors in osteosarcoma: a critical review. J. clin. Oncol., 12, 423-431 (1994).
6. DUBAND, J.L., GIMONA, M., SCATENA, M., SARTORE, S. and SMALL, J.V., Calponin and SM22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation, 55, 1-11 (1993).
7. ENNEKING, W.F., SPANIER, S.S. and GOODMAN, M.A., A system for the surgical staging of musculoskeletal sarcoma. Clin. Orthop., 153, 106-120 (1980).
8. GIACHELLI, C.M., BAE, N., ALMEIDA, M., DENHARDT, D.T., ALPERS, C.E. and SCHWARTZ, S.M., Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. clin. Invest., 92, 1686-1696 (1993).
9. HART, M.J., CALLOW, M.G., SOUZA, B. and POLAKIS, P., IQGAP1, a calmodulin-binding protein with a rasGAP-related domain, is a potential effector for cdc42Hs. EMBO J., 15, 2997-3005 (1996).
10. HASEGAWA, T., HIROSE, T., SEKI, K., HIZAWA, K., USUI, M., ISHII, S. and WAKABAYASHI, J., Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas. Cancer Detect. Prev., 21, 280-287 (1997).
11. IKEDA, T., SHIRASAWA, T., ESAKI, Y., YOSHIKI, S. and HIROKAWA, K., Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J. clin. Invest., 92, 2814-2820 (1993).
12. KATZAV, S., CLEVELAND, J.L., HESLOP, H.E. and PULIDO, D., Loss of the amino-teminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol. cell. Biol., 11, 1912-1920 (1991).
13. LEAVITT, J., GUNNING, P., KEDES, L. and JARIWALLA, R., Smooth muscle α-actin is a transformation-sensitive marker for mouse NIH3T3 and Rat-2 cells. Nature (Lond.), 316, 840-842 (1985).
14. MASUDA, H., MILLER, C., KOEFFLER, H.P., BATTIFORA, H. and CLINE, M.J., Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. U.S.A. 84, 7716-7719 (1987).
15. MASUDA, H., TANAKA, K., TAKAGI, M., OHGAMI, K., SAKAMAKI, T., SHIBATA, N. and TAKAHASHI, K., Molecular cloning and characterization of human non-smooth muscle calponin. J. Biochem., 120, 415-424 (1996).
16. PARKER, C.A., TAKAHASHI, K., TAO, T. and MORGAN, K.G., Agonist-induced redistribution of calponin in contractile vascular smooth muscle cells. Amer. J. Physiol., 267, C1262-C1270 (1994).
17. RHIM, J.S., PARK, D.K., ARNSTEIN, P., HUEBNER, R.J., WEISBURGER, E.K. and NELSON-REES, W.A., Transformation of human cells in culture by N-methyl-N'-nitro-N-nitrosoguanidine. Nature (Lond.), 256, 751-753 (1975).
18. SAPPINO, A.P., SCHURCH, W. and GABBIANI, G., Differentiation repertoir of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab. Invest., 63, 144-161 (1990).
19. SHAH, N.M., GROVES, A.K. and ANDESON, D.J., Alternative neural crest cell fate are instructively promoted by TGFβ superfamily members. Cell, 85, 331-343 (1996).
20. STRASSER, P., GIMONA, M., MOESSLER, H., HERZOG, M. and SMALL, J.V., Mammalian calponin. Identification and expression of genetic variants. FEBS Lett., 330, 13-18 (1993).
21. TAKAHASHI, K., HIWADA, K. and KOKUBU T., Vascular smooth muscle calponin: a novel troponin T-like protein. Hypertension, 11, 620-626 (1988).
22. TAKAHASHI, K., MIWA, A., TAKAGI, M., KOJIMA, A., ESHITA, Y., NARA, Y., YAMORI, Y, HIRABAYASHI, M., KATO, O., AWATA, N., KOBAYASHI, T. and SHIBATA, N., Overexpression of calponin in transgenic rats inhibits intimal arterial smooth muscle cell hyperplasia in the carotid artery model of restenosis. Circulation, 92, Abstract (1995).
23. TAKAHASHI, K. and NADAL-GINARD, B., Molecular cloning and sequence analysis of smooth muscle calponin. J. biol. Chem., 266, 13284-13288 (1991).
24. UCHIDA, A., MYOUI, A., ARAKI, N., YOSHIKAWA, H., SHINTO, Y. and UEDA, T., Neoadjuvant chemotherapy for pediatric osteosarcoma patients. Cancer, 79, 411-415 (1997).
25. URIST, M.R., Bone: formation by autoinduction. Science, 150, 893-899 (1965).
26. WINDER, S.J. and WALSH, M.P., Smooth muscle calponin: inhibition of actomyosin MgATPase and regulation by phosphorylation. J. biol. Chem., 265, 10148-10155 (1990).
27. YAMAGUCHI, A., KATAGIRI, T., IKEDA, T., WOZNEY, J.M., ROSEN, V., WANG, E.A., KAHN, A.J., SUDA, T. and YOSHIKI, S., Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol., 113, 681-687 (1991).
28. YAMAMURA, H., MASUDA, H., IKEDA, W., TOKUYAMA, T., TAKAGI, M., SHIBATA, N., TATSUTA, M. and TAKAHASHI, K., Structure and expression of the human SM22α gene, assignment of the gene to chromosome 11, and repression of the promoter activity by cytosine DNA methylation. J. Biochem., 122, 157-167 (1997).
29. YOSHIKAWA, H., RETTIG, W.J., TAKAOKA, K., ALDERMAN, E., RUP, B., ROSEN, V., WOZNEY, J.M., LANE, J.M., HUVOS, A.G. and GARIN-CHESA, P., Expression of bone morphogenetic proteins in human osteosarcoma. Cancer, 73, 85-91 (1994).